Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
3
|
| gptkbp:bfsParent |
gptkb:healthcare_organization
|
| gptkbp:affects |
gptkb:skincare_product
immune system lymphatic system |
| gptkbp:associated_with |
fatigue
weight loss fever night sweats lymphadenopathy pruritus systemic symptoms erythroderma |
| gptkbp:complications |
infections
skin ulcers lymphoma progression |
| gptkbp:current_use |
gptkb:mycosis_fungoides
gptkb:T-cell_leukemia |
| gptkbp:first_described_by |
1960s
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sézary syndrome
|
| gptkbp:is_characterized_by |
circulating malignant T-cells
|
| gptkbp:is_often_used_in |
adults
elderly |
| gptkbp:is_popular_in |
rare
|
| gptkbp:named_after |
Dr. Alfred Sézary
|
| gptkbp:research_focus |
gptkb:vaccine
biomarkers clinical trials genetic mutations |
| gptkbp:risk_factor |
age
male gender family history of lymphoma |
| gptkbp:social_responsibility |
blood tests
flow cytometry skin biopsy immunophenotyping |
| gptkbp:symptoms |
swollen lymph nodes
thinning hair nail changes red, itchy skin |
| gptkbp:treatment |
radiation therapy
chemotherapy targeted therapy chronic condition phototherapy systemic therapy variable prognosis biologic therapy possible remission |